Versigent — Third Quarter 2026 Earnings Summary

Versigent reported third-quarter 2026 net sales of $2,450 million, representing a 7.2% year-over-year increase, with diluted earnings per share of $1.41. The company raised its full-year 2026 guidance, setting net sales between $9.5 billion and $9.6 billion and free cash flow between $275 million and $325 million. Adjusted EBITDA for the quarter reached $275 million, reflecting an 11.2% margin, while free cash flow totaled $170 million. Additionally, Versigent's Board of Directors declared a quarterly cash dividend of $0.13 per share, payable in December 2026.